T3D Therapeutics
is a North Carolina-based biotechnology company that develops novel therapeutics for the treatment of Alzheimers and neurological disorders... Read moreT3D Therapeutics
is a North Carolina-based biotechnology company that develops novel therapeutics for the treatment of Alzheimers and neurological disorders... Read more
News
Jul 25, 2024
PR Newswire
Press Release: T3D Therapeutics : Leading Alzheimer's Expert Joins T3D Therapeutics' Scientific Advisory Board
Jul 24, 2024
StreetInsider
Press Release: T3D Therapeutics : A Novel Way to Reduce Alzheimer's Amyloid Plaque Burden, Phase 2 Clinical Trial Results of T3D-959 to be Presented by T3D Therapeutics at AAIC
Nov 03, 2023
StreetInsider
Press Release: T3D Therapeutics : T3D Therapeutics Announces Positive Top-Line Results from the Phase 2 PIONEER Trial of T3D-959 in Mild-To-Moderate Alzheimer's Disease
Apr 20, 2021
FE Investegate
T3D Therapeutics: T3D Therapeutics Inc : First Patient Dosed in its Phase 2 Study
Aug 27, 2020
T3D Therapeutics Blog
T3D Therapeutics Blog T3D Therapeutics Receives a Research Award from the Alzheimer’s Association Part the Cloud-Gates Partnership Grant Program
Aug 25, 2020
T3D Therapeutics Blog
T3D Therapeutics Blog Alzheimer’s Association Part The Cloud Grant Program Invests $24 Million in 16 Innovative Research Trials
Feb 12, 2020
MarketScreener
T3D Therapeutics: Leading Alzheimer's Disease Experts Join T3D Therapeutics' Scientific Advisory Board
Feb 11, 2020
T3D Therapeutics Blog
T3D Therapeutics Blog T3D Therapeutics Begins Enrollment in the PIONEER Phase 2 Clinical Trial of T3D-959 in Patients with Mild to Moderate Alzheimer's Disease
Nov 06, 2019
T3D Therapeutics Blog
T3D Therapeutics Blog T3D Therapeutics Closes $15M Financing to Advance Phase 2 Development of T3D-959 in a New Approach to Treating Alzheimer’s Disease.
Nov 05, 2019
The Business Journals: Raleigh/Durham
T3D Therapeutics: RTP drugmaker raises $15M as it moves forward with potential Alzheimer's treatment
T3D Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10